RRM2 and osteosarcoma: Our results revealed that TFRC is clearly overexpressed in osteosarcoma cells and tissues and that the knockdown of TFRC inhibits the transport of iron into osteosarcoma cells, reduces the total intracellular iron content, and inhibits the expression and activity of RRM2, thus inhibiting the proliferation, migration and invasion of osteosarcoma cells.